Howe Laryssa, Craigo Jodi K, Issel Charles J, Montelaro Ronald C
Department of Infectious Disease and Microbiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA 15261, USA.
Department of Molecular Genetics and Biochemistry, School of Medicine, University of Pittsburgh, W1144 Biomedical Science Tower, Pittsburgh, PA 15261, USA.
J Gen Virol. 2005 Jan;86(Pt 1):139-149. doi: 10.1099/vir.0.80374-0.
It has been previously reported that transient corticosteroid immune suppression of ponies experimentally infected with a highly neutralization resistant envelope variant of equine infectious anemia virus (EIAV), designated EIAV(DeltaPND), resulted in the appearance of type-specific serum antibodies to the infecting EIAV(DeltaPND) virus. The current study was designed to determine if this induction of serum neutralizing antibodies was associated with changes in the specificity of envelope determinants targeted by serum antibodies or caused by changes in the nature of the antibodies targeted to previously defined surface envelope gp90 V3 and V4 neutralization determinants. To address this question, the envelope determinants of neutralization by post-immune suppression serum were mapped. The results demonstrated that the neutralization sensitivity to post-immune suppression serum antibodies mapped specifically to the surface envelope gp90 V3 and V4 domains, individually or in combination. Thus, these data indicate that the development of serum neutralizing antibodies to the resistant EIAV(DeltaPND) was due to an enhancement of host antibody responses caused by transient immune suppression and the associated increase in virus replication.
先前已有报道称,对实验感染了一种高度抗中和包膜变异株马传染性贫血病毒(EIAV)(命名为EIAV(DeltaPND))的小马进行短暂的皮质类固醇免疫抑制,会导致出现针对感染的EIAV(DeltaPND)病毒的型特异性血清抗体。当前的研究旨在确定这种血清中和抗体的诱导是否与血清抗体靶向的包膜决定簇特异性变化有关,或者是否由靶向先前定义的表面包膜gp90 V3和V4中和决定簇的抗体性质变化所引起。为解决这个问题,对免疫抑制后血清的中和包膜决定簇进行了定位。结果表明,对免疫抑制后血清抗体的中和敏感性特异性地定位于表面包膜gp90 V3和V4结构域,单独或联合定位。因此,这些数据表明,针对抗性EIAV(DeltaPND)的血清中和抗体的产生是由于短暂免疫抑制引起的宿主抗体反应增强以及相关的病毒复制增加。